XFOR is in the HouseSee the comments on the chart; I intentionally left my chart clean as I see this as a great stock for a training session.
If you are interested, leave a note in the comments.
As always, enjoy every sandwich with a great drink ;)
XFOR trade ideas
XFOR - 140% UPSIDE- Triangle breakout
- buy pullbacks dips
- Tipranks Analyst rating $22 median price target
- The FDA has designated Rare Pediatric Disease status to X4 Pharmaceuticals (XFOR -2.4%) for its lead asset, mavorixafor, for the treatment of WHIM (Warts, Hypogammaglobulinemia, Infections, and Myelokathexis), a rare inherited, immunodeficiency disease caused by genetic mutations in the CXCR4 receptor gene (Vandana Singh, SA)
